Biosimilar Trends Highlight Top News of the Week in Specialty Pharmacy
Top 5 most read articles this week from Specialty Pharmacy Times.
Strategic partnership will advance the use of data in value-based care.
The dream of an HIV cure will only be realized if all 35 million people who are living with the virus adhere to treatment.
Current platforms are not designed for the dynamic needs of today’s specialty pharmacy providers.
Report from Magellan Rx Management shows high-cost specialty drugs require effective management of the medical benefit.
Amgen’s 2017 Trends in Biosimilars report examines commercialization and distribution issues in the biosimilar space.